|
1
|
Hausenloy DJ and Yellon DM: Targeting
myocardial reperfusion injury-the search continues. N Engl J Med.
373:1073–1075. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pagliaro P, Moro F, Tullio F, Perrelli MG
and Penna C: Cardioprotective pathways during reperfusion: Focus on
redox signaling and other modalities of cell signaling. Antioxid
Redox Signal. 14:833–850. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Murry CE, Jennings RB and Reimer KA:
Preconditioning with ischemia: A delay of lethal cell injury in
ischemic myocardium. Circulation. 74:1124–1136. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yue R, Xia X, Jiang J, Yang D, Han Y, Chen
X, Cai Y, Li L, Wang WE and Zeng C: Mitochondrial DNA oxidative
damage contributes to cardiomyocyte Ischemia/Reperfusion-injury in
rats: Cardioprotective role of lycopene. J Cell Physiol.
230:2128–2141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kaczorowski DJ, Nakao A, McCurry KR and
Billiar TR: Toll-like receptors and myocardial
ischemia/reperfusion, inflammation, and injury. Curr Cardiol Rev.
5:196–202. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Prasad A, Stone GW, Holmes DR and Gersh B:
Reperfusion injury, microvascular dysfunction, and
cardioprotection: The ‘dark side’ of reperfusion. Circulation.
120:2105–2112. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Laina A, Gatsiou A, Georgiopoulos G,
Stamatelopoulos K and Stellos K: RNA therapeutics in cardiovascular
precision medicine. Front Physiol. 9:9532018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu H and Fan GC: Role of microRNAs in the
reperfused myocardium towards post-infarct remodelling. Cardiovasc
Res. 94:284–292. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bian B, Yu XF, Wang GQ and Teng TM: Role
of miRNA-1 in regulating connexin 43 in ischemia-reperfusion heart
injury: A rat model. Cardiovasc Pathol. 27:37–42. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen X, Zhang L, Su T, Li H, Huang Q, Wu
D, Yang C and Han Z: Kinetics of plasma microRNA-499 expression in
acute myocardial infarction. J Thorac Dis. 7:890–896.
2015.PubMed/NCBI
|
|
11
|
Zhang XH, Zheng B, Han M, Miao SB and Wen
JK: Synthetic retinoid Am80 inhibits interaction of KLF5 with RAR
alpha through inducing KLF5 dephosphorylation mediated by the
PI3K/Akt signaling in vascular smooth muscle cells. FEBS Lett.
583:1231–1236. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song CL, Liu B, Diao HY, Shi YF, Zhang JC,
Li YX, Liu N, Yu YP, Wang G, Wang JP and Li Q: Down-regulation of
microRNA-320 suppresses cardiomyocyte apoptosis and protects
against myocardial ischemia and reperfusion injury by targeting
IGF-1. Oncotarget. 7:39740–39757. 2016.PubMed/NCBI
|
|
13
|
Su S, Luo, Liu X, Liu J, Peng F, Fang C
and Li B: miR-494 up-regulates the PI3K/Akt pathway via targetting
PTEN and attenuates hepatic ischemia/reperfusion injury in a rat
model. Biosci Rep. 37(pii): BSR201707982017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Y, Liu G, Zhang H and Wang J:
MiRNA-199a-5p influences pulmonary artery hypertension via
downregulating Smad3. Biochem Biophys Res Commun. 473:859–866.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang D, Li Z, Zhang Y, Wang G, Wei M, Hu
Y, Ma S, Jiang Y, Che N, Wang X, et al: Targeting of
microRNA-199a-5p protects against pilocarpine-induced status
epilepticus and seizure damage via SIRT1-p53 cascade. Epilepsia.
57:706–716. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zuo Y, Wang Y, Hu H and Cui W:
Atorvastatin protects myocardium against ischemia-reperfusion
injury through inhibiting miR-199a-5p. Cell Physiol Biochem.
39:1021–1030. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schnitzer SE, Schmid T, Zhou J, Eisenbrand
G and Brüne B: Inhibition of GSK3beta by indirubins restores
HIF-1alpha accumulation under prolonged periods of hypoxia/anoxia.
FEBS Lett. 579:529–533. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang X, Lei S, Long J, Liu X and Wu Q:
MicroRNA-199a-5p inhibits tumor proliferation in melanoma by
mediating hif-1α. Mol Med Rep. 13:5241–5249. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rane S, He M, Sayed D, Vashistha H,
Malhotra A, Sadoshima J, Vatner DE, Vatner SF and Abdellatif M:
Downregulation of miR-199a derepresses hypoxia-inducible
factor-1alpha and Sirtuin 1 and recapitulates hypoxia
preconditioning in cardiac myocytes. Circ Res. 104:879–886. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nishihara M, Miura T, Miki T, Tanno M,
Yano T, Naitoh K, Ohori K, Hotta H, Terashima Y and Shimamoto K:
Modulation of the mitochondrial permeability transition pore
complex in GSK-3β-mediated myocardial protection. J Mol Cell
Cardiol. 43:564–570. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen L, Cai P, Cheng Z, Zhang Z and Fang
J: Pharmacological postconditioning with atorvastatin calcium
attenuates myocardial ischemia/reperfusion injury in diabetic rats
by phosphorylating GSK3β. Exp Ther Med. 14:25–34. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gyulkhandanyan AV, Mutlu A, Freedman J and
Leytin V: Mitochondrial permeability transition pore
(MPTP)-dependent and -independent pathways of mitochondrial
membrane depolarization, cell shrinkage and microparticle formation
during platelet apoptosis. Br J Haematol. 169:142–150. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sivaraman V and Yellon DM: Pharmacologic
therapy that simulates conditioning for cardiac
ischemic/reperfusion injury. J Cardiovasc Pharmacol Ther. 19:83–96.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Heggermont WA, Papageorgiou AP, Quaegebeur
A, Deckx S, Carai P, Verhesen W, Eelen G, Schoors S, van Leeuwen R,
Alekseev S, et al: Inhibition of MicroRNA-146a and overexpression
of its target dihydrolipoyl succinyltransferase protect against
pressure overload-induced cardiac hypertrophy and dysfunction.
Circulation. 136:747–761. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Danielson LS, Park DS, Rotllan N,
Chamorro-Jorganes A, Guijarro MV, Fernandez-Hernando C, Fishman GI,
Phoon CK and Hernando E: Cardiovascular dysregulation of miR-17-92
causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis.
FASEB J. 27:1460–1467. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Verjans R, Peters T, Beaumont FJ, van
Leeuwen R, van Herwaarden T, Verhesen W, Munts C, Bijnen M, Henkens
M, Diez J, et al: MicroRNA-221/222 family counteracts myocardial
fibrosis in pressure overload-induced heart failure. Hypertension.
71:280–288. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Godwin JG, Ge X, Stephan K, Jurisch A,
Tullius SG and Iacomini J: Identification of a microRNA signature
of renal ischemia reperfusion injury. Proc Natl Acad Sci USA.
107:14339–14344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gomez L, Paillard M, Thibault H, Derumeaux
G and Ovize M: Inhibition of GSK3beta by postconditioning is
required to prevent opening of the mitochondrial permeability
transition pore during reperfusion. Circulation. 117:2761–2768.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhai P, Sciarretta S, Galeotti J, Volpe M
and Sadoshima J: Differential roles of GSK-3β during myocardial
ischemia and ischemia/reperfusion. Circ Res. 109:502–511. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nguyen T, Wong R, Wang G, Gucek M,
Steenbergen C and Murphy E: Acute inhibition of GSK causes
mitochondrial remodeling. Am J Physiol Heart Circ Physiol.
302:H2439–H2445. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu J, Ke X, Fu W, Gao X, Zhang H, Wang W,
Ma N, Zhao M, Hao X and Zhang Z: Inhibition of hypoxia-induced
retinal angiogenesis by specnuezhenide, an effective constituent of
ligustrum lucidum Ait., through suppression of the HIF-1α/VEGF
signaling pathway. Molecules. 21(pii): E17562016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang S, Zhang F, Zhao G, Cheng Y, Wu T, Wu
B and Zhang YE: Mitochondrial PKC-ε deficiency promotes
I/R-mediated myocardial injury via GSK3β-dependent mitochondrial
permeability transition pore opening. J Cell Mol Med. 2:2009–2021.
2017. View Article : Google Scholar
|
|
34
|
Flügel D, Görlach A and Kietzmann T:
GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7
and USP28-dependent degradation of HIF-1α. Blood. 119:1292–1301.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang X, Zuo L, Lv Y, Chen C, Yang Y, Xin
H, Li Y and Qian Y: Asiatic acid attenuates myocardial
ischemia/reperfusion injury via Akt/GSK-3β/HIF-1α signaling in rat
H9c2 cardiomyocytes. Molecules. 21:E12482016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Juhaszova M, Wang S, Zorov DB, Nuss HB,
Gleichmann M, Mattson MP and Sollott SJ: The identity and
regulation of the mitochondrial permeability transition pore: Where
the known meets the unknown. Ann NY Acad Sci. 1123:197–212. 2010.
View Article : Google Scholar
|
|
37
|
Zhu H, Ding Y, Xu X, Li M, Fang Y, Gao B,
Mao H, Tong G, Zhou L and Huang J: Prostaglandin E1 protects
coronary microvascular function via the glycogen synthase kinase
3β-mitochondrial permeability transition pore pathway in rat hearts
subjected to sodium laurate-induced coronary microembolization. Am
J Transl Res. 9:2520–2534. 2017.PubMed/NCBI
|
|
38
|
Obame FN, Plin-Mercier C, Assaly R, Zini
R, Dubois-Randé JL, Berdeaux A and Morin D: Cardioprotective effect
of morphine and a blocker of glycogen synthase kinase 3 beta,
SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)- 1H-
pyrrole-2,5-dione], via inhibition of the mitochondrial
permeability transition pore. J Pharmacol Exp Ther. 326:252–258.
2008. View Article : Google Scholar : PubMed/NCBI
|
